Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 23, 2021
Transcriptome and unique cytokine microenvironment of Castleman diseaseAnna Wing, Jason Xu, Wenzhao Meng, et al.
International Journal of Laboratory Hematology|April 17, 2020
Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group studyKathryn Foucar, Eric D Hsi, Sa A Wang, et al.
The American Journal of Surgical Pathology|August 23, 2019
Rosai-Dorfman Disease of the Breast With Variable IgG4+ Plasma Cells: A Diagnostic Mimicker of Other Malignant and Reactive EntitiesJenny C Hoffmann, Chieh-Yu Lin, Siddhartha Bhattacharyya, et al.
Leukemia Research|May 21, 2023
Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology GroupTimothy Kirtek, Weina Chen, Dorottya Laczko, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2018
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology groupCraig R Soderquist, Mark D Ewalt, David R Czuchlewski, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemiaJulia T Geyer, Wayne Tam, Yen-Chun Liu, et al.
Leukemia Research|February 12, 2023
Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutationKran Suknuntha, Julia T Geyer, Keyur Pravinchandra Patel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2018
A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 CriteriaElizabeth Margolskee, Geoff Mikita, Bryan Rea, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 21, 2025
Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution ExperienceOmar Elghawy, Julia Wang, Olivia J Leung, et al.
Blood Advances|September 1, 2023
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomesSheila K Pierson, Megan S Lim, Gordan Srkalovic, et al.
Pageof 18